Healthcare • Biotechnology
EODHD (TTM) · as of Oct 14, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if FTH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
25 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
45 filers reported a long position in FTH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $50.5M | 2M | +5,747.1% |
| Avoro Capital Advisors LLC | $36.1M | 1.4M | New |
| BAKER BROS. ADVISORS LP | $32.2M | 1.3M | New |
| BALYASNY ASSET MANAGEMENT L.P. | $26.1M | 1M | +6,331.3% |
| RA CAPITAL MANAGEMENT, L.P. | $18.1M | 722K | New |
| Vivo Capital, LLC | $18.1M | 722K | Unchanged |
| Logos Global Management LP | $18.1M | 722K | +2,306.7% |
| Fairmount Funds Management LLC | $18.1M | 722K | New |
| Caligan Partners LP | $15.7M | 629.5K | +399.6% |
| B Group, Inc. | $15.3M | 610.2K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.